Jenburkt Pharmaceuticals Ltd — Results, 21-05-2025: Integrated Filing

Jenburkt Pharmaceuticals Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company reported revenue from operations of Rs. 41.05 Cr for the quarter and Rs. 151.69 Cr for the year, showing growth over the previous year. Profit before tax rose to Rs. 11.83 Cr for the quarter and Rs. 43.93 Cr for the year, with net profit after tax at Rs. 8.54 Cr (quarter) and Rs. 32.06 Cr (year). Earnings per share stood at Rs. 19.34 for the quarter and Rs. 72.65 for the year. The company’s independent auditors issued an unmodified opinion, confirming effective internal financial controls and no defaults on loans or borrowings.